Martin Schläpfer
Correction: Early sevoflurane sedation in severe COVID19-related lung injury patients. A pilot randomized controlled trial.
Beck-Schimmer B, Schadde E, Pietsch U, Filipovic M, Dübendorfer-Dalbert S, Fodor P, Hübner T, Schuepbach R, Steiger P, David S, Krüger B, Neff T, Schläpfer M. Correction: Early sevoflurane sedation in severe COVID19-related lung injury patients. A pilot randomized controlled trial. Ann Intensive Care 2024; 14:90.
Jun 16, 2024Correction: Early sevoflurane sedation in severe COVID19-related lung injury patients. A pilot randomized controlled trial.
Jun 16, 2024Ann Intensive Care 2024; 14:90
Beck-Schimmer Beatrice, Schadde Erik, Pietsch Urs, Filipovic Miodrag, Dübendorfer-Dalbert Seraina, Fodor Patricia, Hübner Tobias, Schuepbach Reto Andreas, Steiger Peter, David Sascha, Krüger Bernard D, Neff Thomas A, Schläpfer Martin
Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial.
Beck-Schimmer B, Schadde E, Pietsch U, Filipovic M, Dübendorfer-Dalbert S, Fodor P, Hübner T, Schuepbach R, Steiger P, David S, Krüger B, Neff T, Schläpfer M. Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial. Ann Intensive Care 2024; 14:41.
Mar 27, 2024Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial.
Mar 27, 2024Ann Intensive Care 2024; 14:41
Beck-Schimmer Beatrice, Schadde Erik, Pietsch Urs, Filipovic Miodrag, Dübendorfer-Dalbert Seraina, Fodor Patricia, Hübner Tobias, Schuepbach Reto Andreas, Steiger Peter, David Sascha, Krüger Bernard D, Neff Thomas A, Schläpfer Martin
Interleukin-6 Is an Early Plasma Marker of Severe Postoperative Complications in Thoracic Surgery: Exploratory Results From a Substudy of a Randomized Controlled Multicenter Trial.
Neff T, Braun J, Rana D, Puhan M, Filipovic M, Seeberger M, Stuber F, Neff S, Beck-Schimmer B, Schläpfer M. Interleukin-6 Is an Early Plasma Marker of Severe Postoperative Complications in Thoracic Surgery: Exploratory Results From a Substudy of a Randomized Controlled Multicenter Trial. Anesth Analg 2022; 134:123-132.
Jan 1, 2022Interleukin-6 Is an Early Plasma Marker of Severe Postoperative Complications in Thoracic Surgery: Exploratory Results From a Substudy of a Randomized Controlled Multicenter Trial.
Jan 1, 2022Anesth Analg 2022; 134:123-132
Neff Thomas A, Braun Julia, Rana Dhanu, Puhan Milo, Filipovic Miodrag, Seeberger Manfred, Stuber Frank, Neff Simona B, Beck-Schimmer Beatrice, Schläpfer Martin